Fri.Oct 11, 2024

article thumbnail

Men won all the science Nobels this year. There’s an even bigger problem.

STAT

Since the Nobel Prizes were created in 1901, just 24 women have received awards in the sciences. This year, that number stayed the same: All seven laureates in physics , chemistry , and physiology or medicine were men.  Some scientists have expressed frustration about the lack of women in this year’s awardees, particularly the omission of two women who contributed to the work honored for the prize in physiology or medicine.

362
362
article thumbnail

SAEM Clinical Images Series: A Blistery Mystery

ALiEM - Pharm Pearls

A 76-year-old female presented with a lingering cough and an oral lesion to the left lower cheek. She reported ten days of improving flu-like symptoms but had a persistent cough and nasal congestion. On the day of presentation, she developed a painful, intermittently bleeding “blood blister” to the left lower cheek that had increased in size, as well as new red spots on her arms and legs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: Encampment sweeps threaten homeless people’s health

STAT

Recently, California Gov. Gavin Newsom granted $130.7 million for local governments addressing homelessness, including clearing encampments. It comes in the wake of  a June Supreme Court ruling that gave cities full authority to implement and enforce policies that would allow them to clear encampments as they see fit. In early August, Newsom was even filmed removing homeless people’s belongings from public view in Mission Hills in Los Angeles County.

Cart Fill 360
article thumbnail

BMS’ next act for Cobenfy — and other highs and lows in Alzheimer’s

PharmaVoice

The Alzheimer’s space is booming, from a new use for a schizophrenia drug to discovered pathways linked to the disease — but there’s been stumbles too.

130
130
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle

STAT

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire. Last week, the Food and Drug Administration declared an end to the shortage of Eli Lilly’s tirzepatide, sold under the brand name Mounjaro for diabetes and Zepbound for obesity. The move was a clear warning to compounders that they can no longer make copycat versions of the drugs — a process that is only permitted when the medications are on

article thumbnail

Sanofi may have found a buyer for its consumer health business

BioPharma Dive

The French pharmaceutical giant said it’s in negotiations to sell a controlling stake of Opella to the private equity firm CD&R, in a deal that reportedly could be worth more than $16 billion.

111
111

More Trending

article thumbnail

Sanofi in talks to sell stake in consumer health spinout

pharmaphorum

Rumours that Sanofi was in discussion with private equity groups over the sale of its consumer health business Opella have been confirmed – at least partially.The French pharma group confirmed this morning that it has entered into talks with US-based Clayton Dubilier & Rice to sell a controlling 50% stake in the unit for what has been estimated by Reuters to be in the region of €15 billion ($16.4 billion).

105
105
article thumbnail

STAT+: In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list

STAT

The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, from its shortage list, and, for the time being, would not pursue regulatory action against certain compounding pharmacies making copies of the drugs.  The decision, disclosed in a court filing, marked a stark reversal.

article thumbnail

Capsules of controversy: India’s growing appetite for dietary supplements

Express Pharma

The Food Safety and Standards Authority of India (FSSAI) uncovered a rather disturbing trend last year. A nationwide enforcement drive revealed that over 15 per cent of tested health supplement samples failed to meet regulatory standards. This revelation highlights the growing pains of a sector that promises health benefits to millions of consumers.

article thumbnail

STAT+: John Maraganore on his new biotech venture, R&D vivacity and Nobel award-winning AI

STAT

It’s been two years since Alnylam’s founding CEO John Maraganore announced he was stepping back from the company. And in that time, he’s built up a bit of a persona for himself as biotech’s elder statesman. Multiple venture capital firms have enlisted his help in starting new companies and many founders aspire for him to join their boards.

313
313
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

CDSCO committee recommends Wockhardt’s novel antibiotic Miqnaf for CABP treatment

Express Pharma

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has provided a recommendation for Wockhardt’s novel antibiotic Miqnaf (nafithromycin) for the treatment of Community-Acquired Bacterial Pneumonia (CABP) in adults. The SEC recommendation is based on a comprehensive review of the product dossier, which includes non-clinical, US/EU Phase 1, Global Phase 2, and India Phase 3 clinical studies conducted over the last 15 years.

95
article thumbnail

Opinion: I swore I wouldn’t become a psychiatrist

STAT

I entered medical school absolutely certain of one thing: I didn’t want to be a psychiatrist like my father. I’m sure someone like Freud could come up with a deep therapeutic reason for why I didn’t want to follow in my father’s footsteps. Or, maybe I could ask the surgeon who belittled me as a medical student and asked, “Are you going to go into the same field as your daddy?

article thumbnail

University of Central Lancashire partners with Brinton Healthcare UK to explore nanoparticle technology for skin disease treatment

Express Pharma

The University of Central Lancashire (UCLan) has signed a Memorandum of Understanding (MoU) with Brinton Healthcare UK to explore the use of nanoparticle technology in the treatment of skin diseases. The research, led by Professor of Pharmaceutical Technology and Drug Delivery Kamalinder Singh, will investigate innovative solutions for dermatological therapies using topical nanocarriers.

93
article thumbnail

STAT+: Pharmalittle: We’re reading about alleged Pfizer threats, industry payments to peer reviewers, and more

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, in fact, is already overflowing. Besides stopping to observe ancient rituals, we plan to celebrate with our Pharmalot ancestor who turns the 90th page on the proverbial calendar, and hang with a couple of our short people.

273
273
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Lawmaker asks FTC to probe Novo/Catalent deal

pharmaphorum

US Senator Elizabeth Warren asks FTC to scrutinise $16.5bn Novo Holdings/Catalent merger and sale of manufacturing plants to Novo Nordisk.

114
114
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

258
258
article thumbnail

As MFP Approaches, Transparency Is More Important Than Ever

Drug Channels

Today’s guest post comes from Angie Franks, Chief Executive Officer of Kalderos. Angie discusses how the Maximum Fair Price provision of the Inflation Reduction Act of 2022 will challenge providers, pharmacies, and manufacturers. She explains how Kalderos’ Truzo platform could reduce duplicate claims and address compliance issues. To learn more, register for Kalderos’ October 25 webinar Cracking the MFP Code: How Flexible Technology Helps You Navigate an Evolving Landscape.

98
article thumbnail

A setback for the Denali-Sanofi partnership

STAT

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  This newsletter was penned in the company of some mastodon fossils in New York. They say good morning, too.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Covid inquiry: Pharmacist lays bare difficulties faced by sector

The Pharmacist

A pharmacist has given a first-hand account of the difficult experiences he and pharmacy teams faced during the Covid-19 pandemic, as part of an independent inquiry into the UK’s response to the outbreak. From major issues with ordering and storing stock, working night shifts to keep up with demands, and sourcing their own personal protective […] The post Covid inquiry: Pharmacist lays bare difficulties faced by sector appeared first on The Pharmacist.

105
105
article thumbnail

Roche gets FDA green light for breast cancer drug Itovebi

pharmaphorum

FDA gives Roche the first approval for PI3K inhibitor Itovebi, clearing the drug for certain types of advanced breast cancer

111
111
article thumbnail

Jane Koo on leading regulatory affairs at CTMC: A journey from mAbs to cellular therapies

Outsourcing Pharma

Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization of innovative cellular therapies.

96
article thumbnail

Facing Potential Drug Shortages, FDA Delays Enforcement of DSCSA Compliance Deadline, with Stipulations

Pharmaceutical Commerce

The now-11-year odyssey to track drugs by item through the supply chain will be under a regulatory exemption for up to two years.

105
105
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Vaccines “essential” for addressing AMR, says WHO

European Pharmaceutical Review

A new report by the World Health Organization (WHO) has emphasised the importance of vaccines in addressing antimicrobial resistance (AMR) globally. For example, the report explained that “vaccines against 24 pathogens could reduce the number of antibiotics needed by 22 percent or 2.5 billion defined daily doses globally every year”. Vaccines are a key part of helping to reducing AMR because they “prevent infections… and slow the emergence and spread of drug-resistant pathogens”, WHO explained.

article thumbnail

Women in Science: Sharmeen Roy - 'pharmacy is the perfect blend of all my favourite subjects'

Outsourcing Pharma

At the forefront of precision dosing, Sharmeen leads DoseMe's efforts to transform personalized medicine from lab research to bedside application.

70
article thumbnail

FDA clears Roche breast cancer drug; Turnstone lays off 60% of staff

BioPharma Dive

Itovebi is part of a push by Roche to make new inroads in breast cancer. Elsewhere, Turnstone is trimming preclinical research and Gritstone bio is working on a bankruptcy deal.

62
article thumbnail

CPHI Milan 2024: Pharma Industry Growth and Investment

PharmaTech

Pharmaceutical Technology Europe spoke with John McQuaid, president and managing director at Almac Pharma Services, at CPHI Milan 2024, held October 8–10, in Milan, Italy, about how the pharmaceutical industry is growing and what might drive investment in the future.

59
article thumbnail

FDA approves new treatment for hemophilia A or B

World Pharma News

Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors (neutralizing antibodies).

52
article thumbnail

BIO-Europe's 30th Anniversary Landmark Event in Stockholm

pharmaphorum

BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and dealmaking forward through one-to-one partnering. Today, it proudly holds the mantle as Europe’s flagship partnering event.

52
article thumbnail

Be Proactive About Prostate Health

Compounding Pharmacy of America

Discover how supplements can support prostate health with natural ingredients designed to promote overall well-being. The post Be Proactive About Prostate Health appeared first on The Compounding Pharmacy of America.

article thumbnail

Evonik Wins Award at CPHI Milan for Plant-based Parenteral Drug Delivery Adjuvant

PharmaTech

Evonik won the CPHI Excellence in Pharma Award in the “Sustainability” category in recognition of its plant-based squalene, PhytoSquene, used in parenteral drug delivery applications.

52
article thumbnail

Amber Specialty Pharmacy Named 2024 Specialty Pharmacy of The Year by NASP, The National Association of Specialty Pharmacy

Amber

OMAHA, Neb.–( BUSINESS WIRE )–Amber Specialty Pharmacy, a subsidiary of Hy-Vee, Inc., has been named the 2024 Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP) at this year’s NASP Annual Meeting & Expo. This prestigious award highlights Amber Specialty Pharmacy’s dedication to patient satisfaction, service excellence, cost management, community involvement and leadership in specialty pharmacy innovation.

article thumbnail

LogiPharma USA 2024: Confronting Conflicting Priorities Between Supply Chain Partners

Pharmaceutical Commerce

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses how to handle opposing concerns between supply chain teams and offers communication solutions.